Insights

Innovative Technology XRpro Sciences utilizes a proprietary, label-free X-ray fluorescence technology that enables high throughput screening of complex ion channels and transporters, offering a distinct advantage for pharmaceutical companies seeking efficient and reliable assay development solutions.

Expanding R&D Capabilities With a focus on challenging targets like ion channels and transporters, XRpro Sciences provides valuable services that can complement in-house research efforts, appealing to biotech firms aiming to accelerate drug discovery pipelines.

Market Potential Operating within the biotechnology research industry and serving clients needing innovative high-throughput screening services, XRpro Sciences is well-positioned to grow by targeting pharmaceutical and biotech companies investing in new drug development initiatives.

Flexible Assay Solutions The company's technology works in complex biological matrices such as serum and high DMSO conditions, enabling research in realistic physiological environments, which is attractive to drug developers looking for versatile assay platforms.

Potential Collaborations XRpro Sciences’ emphasis on advancing ion channel and transporter research presents opportunities for strategic partnerships with companies involved in neurological, cardiovascular, and other disease areas where these targets are critical.

Similar companies to Caldera Pharmaceuticals, Inc

Caldera Pharmaceuticals, Inc Tech Stack

Media & News

Caldera Pharmaceuticals, Inc's Email Address Formats

Caldera Pharmaceuticals, Inc uses at least 1 format(s):
Caldera Pharmaceuticals, Inc Email FormatsExamplePercentage
First.Last@xrpro.comJohn.Doe@xrpro.com
33%
FLast@xrpro.comJDoe@xrpro.com
17%
First.Last@xrpro.comJohn.Doe@xrpro.com
33%
FLast@xrpro.comJDoe@xrpro.com
17%

Frequently Asked Questions

Where is Caldera Pharmaceuticals, Inc's headquarters located?

Minus sign iconPlus sign icon
Caldera Pharmaceuticals, Inc's main headquarters is located at One Kendall Square, B2002 Cambridge, MA 02139 United States. The company has employees across 1 continents, including North America.

What is Caldera Pharmaceuticals, Inc's phone number?

Minus sign iconPlus sign icon
You can contact Caldera Pharmaceuticals, Inc's main corporate office by phone at . For more prospecting data, LeadIQ has access to up-to-date and accurate contact information within our platform. Find, capture, and sync contact data to your CRM and sales tools in one click.

What is Caldera Pharmaceuticals, Inc's official website and social media links?

Minus sign iconPlus sign icon
Caldera Pharmaceuticals, Inc's official website is xrpro.com and has social profiles on LinkedIn.

What is Caldera Pharmaceuticals, Inc's SIC code NAICS code?

Minus sign iconPlus sign icon
Caldera Pharmaceuticals, Inc's SIC code is 8733 - Noncommercial Research Organizations NAICS code is 541714 - Research and Development in Biotechnology (except Nanobiotechnology).

How many employees does Caldera Pharmaceuticals, Inc have currently?

Minus sign iconPlus sign icon
As of September 2025, Caldera Pharmaceuticals, Inc has approximately 11 employees across 1 continents, including North America. Key team members include President & Ceo: R. C.Director Of Assay Development: S. W.. Explore Caldera Pharmaceuticals, Inc's employee directory with LeadIQ.

What industry does Caldera Pharmaceuticals, Inc belong to?

Minus sign iconPlus sign icon
Caldera Pharmaceuticals, Inc operates in the Biotechnology Research industry.

What is Caldera Pharmaceuticals, Inc's email format?

Minus sign iconPlus sign icon
Caldera Pharmaceuticals, Inc's email format typically follows the pattern of First.Last@xrpro.com. Find more Caldera Pharmaceuticals, Inc email formats with LeadIQ.

Caldera Pharmaceuticals, Inc

Biotechnology ResearchMassachusetts, United States11-50 Employees

XRpro Sciences, Inc. provides high-value services -- from assay development and high throughput screening through data analysis -- for ion channels and transporters using its proprietary, lablel-free XRpro® technology. XRpro® technology, based on X-ray fluorescence, is a novel method that enables high throughput assessment of ion channels and transporters including challenging assays that are difficult or impossible to conduct using other technologies. XRpro Sciences is dedicated to solving the challenges scientists face by bringing the value of XRpro® technology to their ion channel and transporter research and drug development activities. Our services combine the expertise and capabilities of our scientific team with a collaborative environment to provide new scientific insights and promote development of quality drug candidates. Advantages of XRpro® Technology: - Label-free - No dyes or radiolabels - Works in complex matrices - Serum, high DMSO, opaque solutions - Broad range of targets - ion channels, transporters, and other challenging targets - Straightforward assay implementation - uses standard cell biology, microplates, automation, and assay procedures

Section iconCompany Overview

Headquarters
One Kendall Square, B2002 Cambridge, MA 02139 United States
Phone number
Website
xrpro.com
SIC Code
8733 - Noncommercial Research Organizations
NAICS Code
541714 - Research and Development in Biotechnology (except Nanobiotechnology)
Employees
11-50

Section iconMedia & News

Section iconFunding & Financials

  • $1M$10M

    Caldera Pharmaceuticals, Inc's revenue is estimated to be in the range of $1M$10M

Section iconFunding & Financials

  • $1M$10M

    Caldera Pharmaceuticals, Inc's revenue is estimated to be in the range of $1M$10M

Ready to create more pipeline?

Get a demo and discover why thousands of SDR and Sales teams trust
LeadIQ to help them build pipeline confidently.

© LeadIQ, Inc. All rights reserved.